Further evidence of a primary mucosal defect in coeliac disease
- PMID: 648934
- PMCID: PMC1411936
- DOI: 10.1136/gut.19.4.253
Further evidence of a primary mucosal defect in coeliac disease
Abstract
Subfractions of fraction 9, obtained from a peptic-tryptic-pancreatinic digest of wheat gliadin, were subjected to in vitro mucosal digestion and the filtrates examined for residual peptides. Small-intestinal mucosa from four groups of individuals were studied-eight patients with coeliac disease in remission; eight healthy controls; nine first degree relatives of patients with coeliac disease, and six children with recurrent diarrhoea investigated for possible coeliac disease, but in whom the diagnosis was excluded. The highest amounts of residual peptides (measured by scanning densitometer) were detected after digestion with mucosa from patients with coeliac disease and the lowest amounts with the control groups. The results obtained with the group of relatives fell between those of the coeliac disease and control groups, while the recurrent diarrhoea group overlapped the relatives and controls. The residual peptides were derived chiefly from the B-type subfractions of subfractions 1 and 2, obtained by ion-exchange chromatography of fraction 9. These subfractions are rich in glutamine/glutamic acid and proline and have a molecular weight (apparent) of not greater than 1500 Daltons. The results lend further support to the hypothesis of an enzyme deficiency in coeliac disease. A partial enzyme deficiency may exist in some first-degree relatives and in some children with recurrent diarrhoea but with histology of the small intestine within normal limits. HLA-B8 antigen is not correlated with this deficiency, but, when the two factors are associated, they could be related to the manifestation and severity of coeliac disease.
Similar articles
-
Partial in vitro digestion of active gliadin-related peptides in celiac disease.J Protein Chem. 1998 Nov;17(8):739-44. doi: 10.1023/a:1020765932203. J Protein Chem. 1998. PMID: 9988520
-
Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease.Clin Chim Acta. 1988 Sep 15;176(3):279-89. doi: 10.1016/0009-8981(88)90187-8. Clin Chim Acta. 1988. PMID: 3180479
-
Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.Clin Chim Acta. 1982 Aug 18;123(3):311-9. doi: 10.1016/0009-8981(82)90176-0. Clin Chim Acta. 1982. PMID: 6811164
-
[Etiopathogenesis of celiac disease: the attraction and flimsiness of hypotheses].Presse Med. 1985 May 4;14(18):1027-30. Presse Med. 1985. PMID: 3158948 Review. French.
-
In vivo gluten ingestion in coeliac disease.Dig Dis. 1998 Nov-Dec;16(6):337-40. doi: 10.1159/000016887. Dig Dis. 1998. PMID: 10207218 Review.
Cited by
-
Sequential morphologic and biochemical studies of naturally occurring wheat-sensitive enteropathy in Irish setter dogs.Dig Dis Sci. 1987 Feb;32(2):184-94. doi: 10.1007/BF01297107. Dig Dis Sci. 1987. PMID: 3026759
-
In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease.J Protein Chem. 1995 Jul;14(5):335-9. doi: 10.1007/BF01886790. J Protein Chem. 1995. PMID: 8590601
-
Partial in vitro digestion of active gliadin-related peptides in celiac disease.J Protein Chem. 1998 Nov;17(8):739-44. doi: 10.1023/a:1020765932203. J Protein Chem. 1998. PMID: 9988520
-
Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.Gut. 1984 Sep;25(9):919-24. doi: 10.1136/gut.25.9.919. Gut. 1984. PMID: 6381246 Free PMC article.
-
Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.Gut. 1992 Nov;33(11):1487-92. doi: 10.1136/gut.33.11.1487. Gut. 1992. PMID: 1452073 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials